Search

Failed Clinical Trial Puts Eli Lilly Cancer Drug in Limbo

FAILED CLINICAL TRIAL PUTS ELI LILLY CANCER DRUG IN LIMBO

An Eli Lilly drug on the market for a rare form of cancer is now in limbo, after it failed a trial needed to retain the FDA approval...

Leicester City defender Benalouane joins Nottingham Forest

LEICESTER CITY DEFENDER BENALOUANE JOINS NOTTINGHAM FOREST

The Tunisia international has become the first signing of Martin O'Neill after agreeing on a year and a half deal with the Reds

 
 
 
 
 
 
Medical detection dogs lick their diabetic owner's face during a hypo

MEDICAL DETECTION DOGS LICK THEIR DIABETIC OWNER'S FACE DURING A HYPO

Type 1 diabetic Claire Moon (pictured with her specially-trained dog Magic) was one of the participants in the study by the University...

Why It's OK Halloween 2018 Didn't Kill Michael Myers

WHY IT'S OK HALLOWEEN 2018 DIDN'T KILL MICHAEL MYERS

In an exclusive chat, Halloween 2018 producer Ryan Turek has explained why the movie didn't kill off iconic slasher Michael Myers....

 
 
 
Nottingham Forest appoint club legend O'Neill as new manager

NOTTINGHAM FOREST APPOINT CLUB LEGEND O'NEILL AS NEW MANAGER

The former Republic of Ireland manager has returned to the City Ground to take over the club he won two European Cups with as a player

IMMUNOCORE NAMES EX-ASTRAZENECA, BRISTOL-MYERS EXECUTIVE AS R&D CHIEF

Immunocore has named David Berman as its head of research and development. Berman spent the past decade overseeing the rise of immuno-oncology...

 
 
 
Myers-Briggs® Personality Types Of True Blood Characters

MYERS-BRIGGS® PERSONALITY TYPES OF TRUE BLOOD CHARACTERS

True Blood , based on The Southern Vampire Mysteries book series by Charlaine Harris, is a show that brought a bit of horror and gore...

Immersive Labs, a Bristol-based startup founded by a former GCHQ researcher, raises $8m 

IMMERSIVE LABS, A BRISTOL-BASED STARTUP FOUNDED BY A FORMER GCHQ RESEARCHER, RAISES $8M 

 
 
 
Jared Goff explains his 4th down run that sealed the game for the Rams

JARED GOFF EXPLAINS HIS 4TH DOWN RUN THAT SEALED THE GAME FOR THE RAMS

Jared Goff talks with Chris Myers after the Los Angeles Rams Divisional playoff win against the Dallas Cowboys,

Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More

NOTES FROM THE JPM19 VORTEX: PRICE APOCALYPSE, CELGENE FALLOUT & MORE

[ Editor's note: Ben Fidler and Sarah de Crescenzo coauthored this report .] It is here, and then it is gone. But by the time everyone...

 
 
 
The Myers-Briggs® Personality Types Of Adventure Time Characters

THE MYERS-BRIGGS® PERSONALITY TYPES OF ADVENTURE TIME CHARACTERS

Related: Why Two Adventure Time Games Are Leaving Digital Stores Now that the series finale is long over with, let's take some time...

Nic+Zoe name Avra Myers as new Chief Merchant

NIC+ZOE NAME AVRA MYERS AS NEW CHIEF MERCHANT

Boston-based womenswear brand Nic+Zoe has named co-founder of Club Monaco, Avra Myers, as the company's new Chief Merchant. Myers spent...

 
 
 
Club Monaco founder joins Nic+Zoe

CLUB MONACO FOUNDER JOINS NIC+ZOE

Club Monaco co-founder Avra Myers has joined American fashion brand Nic+Zoe as chief merchant.

Star Wars: Age of Republic - Padmé Amidala 1

STAR WARS: AGE OF REPUBLIC - PADMÉ AMIDALA 1

STAR WARS: AGE OF REPUBLIC - PADMÉ AMIDALA 1. 2018. Ink on bristol board with digital color, 11 × 17″. In stores March 6. Full details...

 
 
 
Star Wars: Age of Republic - Anakin Skywalker 1

STAR WARS: AGE OF REPUBLIC - ANAKIN SKYWALKER 1

STAR WARS: AGE OF REPUBLIC - ANAKIN SKYWALKER 1. 2018. Ink on bristol board with digital color, 11 × 17″.

Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More

BIO ROUNDUP: $74B FOR CELGENE, TWO CAR-T TALES, READY FOR SF & MORE

In 2018, my Exome colleagues and I published hundreds of stories about health, medicine, the biopharma industry, government policy,...

 
 
 
Here's why Bristol-Myers Squibb's record-breaking $74 billion biotech deal is facing investor backlash

HERE'S WHY BRISTOL-MYERS SQUIBB'S RECORD-BREAKING $74 BILLION BIOTECH DEAL IS FACING INVESTOR BACKLASH

Bristol-Myers Squibb said on Thursday that it would acquire the biotech Celgene in a $74 billion deal . The two companies each face...